A new program shows promise for improving patient medication adherence. Find out how it works.
A Kaiser Permanente study found that a new way to test for HPV has the potential to increase efficiency and decrease waste.
With the high efficacy and dire diagnosis, there will be demand for both Kymriah and Yescarta. Here’s how to manage the monetary impact.
CAR-T therapies have high price tags so it’s important to understand your patient population and budget impact.
As more specialty drugs are approved, cost control strategies are key.
Analysts discuss how pharmacoeconomics will make a difference in treatment decisions.
New updates in insulin products, as well as non-pharma therapies are on the horizon for diabetes.
There now exist numerous treatment options for multiple myeloma but how best to sequence them is still under study
As part of efforts to combat the opioid epidemic, Cigna removes prior authorization from medication-assisted treatment for opioid use disorder.
Do copay assistance program offer a long-term solution for patients? Experts weigh in.